Zomedica Pharmaceuticals Corp is a veterinary-focused healthcare company dedicated to developing innovative diagnostic and therapeutic products for companion animals, particularly dogs and cats
The company aims to enhance the quality of care for pets and improve their health outcomes through its advanced diagnostic tools. Zomedica's flagship product line includes diagnostics that help veterinarians detect and monitor various health conditions, empowering them to make informed decisions regarding treatment options. With a commitment to improving animal health, Zomedica seeks to support veterinary practices with effective solutions that ultimately lead to better pet care.
Zomedica Corp (AMEX: ZOM) launches 2 new canine assays for its TRUFORMA platform. NT-proBNP test detects heart failure, progesterone test helps with breeding timing.
Zomedica Corp. expands into Costa Rica with SIRE Veterinario as exclusive distributor. Strategic partnership aims to bring advanced veterinary solutions to local veterinarians.
Companies Reporting Before The Bell • Mach Natural Resources (NYSEMNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQIDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSETAK) is likely to report earnings for its fourth quarter. • Exela Technologies NASDAQ:XELANASDAQXELA)
